NCT04202367View on ClinicalTrials.gov

The Efficacy of Different Bupivacaine Concentrations in Pediatric Patients Undergoing Transversus Abdominis Plane Block

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

June 1, 2017

Study Completion Date

July 1, 2017

Conditions
Transversus Abdominis Plane Block
Interventions
DRUG

1 mg.kg-1 bupivacaine 0.25%

Ultrasound-guided transversus abdominis plane block for unilateral inguinal hernia repair surgery.

DRUG

1 mg.kg-1 bupivacaine 0.125%

Ultrasound-guided transversus abdominis plane block for unilateral inguinal hernia repair surgery.

All Listed Sponsors
lead

Istanbul University

OTHER

NCT04202367 - The Efficacy of Different Bupivacaine Concentrations in Pediatric Patients Undergoing Transversus Abdominis Plane Block | Biotech Hunter | Biotech Hunter